« Previous
Next »
Thrombosis Research
Volume 121, Issue 3
, Pages 333-338
, 2007
Fibrinogen Aα-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism
References
- . Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood. 2003;101:3008–3013
- . The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood. 2000;96:988–995
- Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost. 2000;84:595–600
- . Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood. 2002;100:743–754
- . The FXIII Val 34 Leu mutation and the risk of venous thrombosis. Thromb Haemost. 2000;84:1117–1118
- . The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica. 2000;85:293–297
- . Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol. 2004;24:1558–1566
- . Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation. 2003;107:2326–2330
- . alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood. 2000;96:1177–1179
- Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study. J Thromb Haemost. 2006;4:793–799
- . Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA. 1990;263:2753–2759
- Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood. 2000;96:2479–2486
- Is APC resistance a risk factor for venous thromboembolism in patients over 70 years?. Thromb Haemost. 2002;88:587–591
- . Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood. 1999;93:906–908
- . The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?. Blood Coagul Fibrinolysis. 2006;17:533–538
- . Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Am J Epidemiol. 2006;164:101–109
- . Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation. 1999;99:2423–2426
- . Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: identification of polymorphisms at positions A alpha 312 and B beta 448. Blood. 1993;82:2117–2124
- The alpha fibrinogen T/A312 polymorphism in the ECTIM study. Thromb Haemost. 1998;79:1057–1058
- Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis. Brit J Haematol. 2002;119:169–175
☆ GLG collected data, analyzed data and wrote the paper; BD performed research and wrote the paper; KL collected data; VM performed research; SR performed research; MTB collected data; FC collected data; DM designed research; EO designed research and collected data; YG designed research and wrote the paper.
PII: S0049-3848(07)00208-3
doi: 10.1016/j.thromres.2007.05.003
© 2007 Elsevier Ltd. All rights reserved.
« Previous
Next »
Thrombosis Research
Volume 121, Issue 3
, Pages 333-338
, 2007
